Early Detection of Abnormal Prion Protein in Genetic Human Prion Diseases Now Possible Using Real-Time QUIC Assay

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Sano, Kazunori ^a,h   Satoh, Katsuya ^a   Atarashi, Ryuichiro ^a,h   Takashima, Hiroshi ^b   Iwasaki, Yasushi ^c   Yoshida, Mari ^c   Sanjo, Nobuo ^d   Murai, Hiroyuki ^e   Mizusawa, Hidehiro ^d   Schmitz, Matthias ^f   Zerr, Inga ^f   Kim, Yong Sun ^g   Nishida, Noriyuki ^a,h  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e ASO IIZUKA HOSPITAL   (Japan)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

^g Hallym University   (South Korea)

^h NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PRION PROTEIN; PROTEIN 14 3 3; TAU PROTEIN;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATAL FAMILIAL INSOMNIA; FEMALE; GENE MUTATION; GENETIC DISORDER; HUMAN; IN VITRO STUDY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRION DISEASE; PROTEIN DETERMINATION; REAL TIME QUAKING INDUCED CONVERSION; WESTERN BLOTTING;

14-3-3 PROTEINS; ADULT; AGED; BIOLOGICAL MARKERS; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PRION DISEASES; PRIONS; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE; TAU PROTEINS;

EID: 84872851444     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054915     Document Type: Article

References (7)

1. Popova SN, Tarvainen I, Capellari S, Parchi P, Hannikainen P, et al. (2012) Divergent clinical and neuropathological phenotype in a Gerstmann-Straussler-Scheinker P102L family. Acta Neurol Scand 126(5): 315-23.
2. Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, et al. (2011) Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17: 175-178.
3. Satoh K, Tobiume M, Matsui Y, Mutsukura K, Nishida N, et al. (2010) Establishment of a standard 14-3-3 protein assay of cerebrospinal fluid as a diagnostic tool for Creutzfeldt-Jakob disease. Lab Invest 90: 1637-1644.
4. Ladogana A, Sanchez-Juan P, Mitrová E, Green A, Cuadrado-Corrales N, et al. (2009) Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neurol 256: 1620-1628.
5. Webb TE, Poulter M, Beck J, Uphill J, Adamson G, et al. (2008) Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain 131 (Pt 10): 2632-2646.
6. Capellari S, Strammiello R, Saverioni D, Kretzschmar H, Parchi P, (2011) Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis. Acta Neuropathol 121(1): 21-37.
7. Piccardo P, Dlouhy SR, Lievens PM, Young K, Bird TD, et al. (1998) Phenotypic variability of Gerstmann-Straussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neuro 57(10): 979-988.